NVIDIA Teams with National Cancer Institute, U.S. Department of Energy to Create AI Platform for Accelerating Cancer Research

'CANDLE' AI Software to Deliver a Decade of Cancer Advances in Just Five Years
 NVIDIA Teams with National Cancer Institute, U.S. Department of Energy to Create AI Platform for Accelerating Cancer Research

About NVIDIA
NVIDIA (NASDAQ: NVDA) is the AI computing company. Its invention of the GPU in 1999 sparked the growth of the PC gaming market, redefined modern computer graphics and revolutionized parallel computing. More recently, GPU deep learning ignited modern AI -- the next era of computing -- with the GPU acting as the brain of computers, robots and self-driving cars that can perceive and understand the world. More information at http://nvidianews.nvidia.com/.

Certain statements in this press release including, but not limited to, statements regarding the impact, benefits and goals of the Cancer Moonshot, the CANDLE AI framework, the combination of NVLink-enabled Pascal GPU architectures, and NVIDIA DGX-1; NVIDIA's participation in CANDLE; AI and deep learning techniques being essential to achieve the Cancer Moonshot objectives; expected gains in training neural networks for cancer research; large-scale data analytics and deep learning being central to Lawrence Livermore National Laboratory's missions; NVIDIA being at the forefront of accelerated machine learning; and CORAL/Sierra architectures being critical to developing scalable deep learning algorithms are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners' products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of our products or technologies when integrated into systems; as well as other factors detailed from time to time in the reports NVIDIA files with the Securities and Exchange Commission, or SEC, including its Form 10-Q for the fiscal period ended July 31, 2016. Copies of reports filed with the SEC are posted on the company's website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2016 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, Pascal and DGX-1 are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. Other company and product names may be trademarks of the respective companies with which they are associated.

About NVIDIA
NVIDIA (NASDAQ: NVDA) is the AI computing company. Its invention of the GPU in 1999 sparked the growth of the PC gaming market, redefined modern computer graphics and revolutionized parallel computing. More recently, GPU deep learning ignited modern AI -- the next era of computing -- with the GPU acting as the brain of computers, robots and self-driving cars that can perceive and understand the world. More information at http://nvidianews.nvidia.com/.

Certain statements in this press release including, but not limited to, statements regarding the impact, benefits and goals of the Cancer Moonshot, the CANDLE AI framework, the combination of NVLink-enabled Pascal GPU architectures, and NVIDIA DGX-1; NVIDIA's participation in CANDLE; AI and deep learning techniques being essential to achieve the Cancer Moonshot objectives; expected gains in training neural networks for cancer research; large-scale data analytics and deep learning being central to Lawrence Livermore National Laboratory's missions; NVIDIA being at the forefront of accelerated machine learning; and CORAL/Sierra architectures being critical to developing scalable deep learning algorithms are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners' products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of our products or technologies when integrated into systems; as well as other factors detailed from time to time in the reports NVIDIA files with the Securities and Exchange Commission, or SEC, including its Form 10-Q for the fiscal period ended July 31, 2016. Copies of reports filed with the SEC are posted on the company's website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2016 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, Pascal and DGX-1 are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. Other company and product names may be trademarks of the respective companies with which they are associated.

Media Contacts

Global contacts for media inquiries.

All Contacts

Stay Informed

Newsroom updates delivered to your inbox.

Subscribe